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Abstract: The objectives of this study were to evaluate endometritis incidence and possible causes, and to assess the different therapy
options. From a total of 1300 cows, endometritis was diagnosed in 23.07%, with clinical endometritis in 15.31% and subclinical
endometritis in 7.77%. Previous dystocia resulted in 40.59% of the clinical endometritis and 47.52% of the subclinical endometritis (P <
0.05). Placental retention caused clinical and subclinical endometritis in 43.18% and 37.50% of the cows, respectively (P < 0.05). Body
condition score 2 resulted in the highest endometritis rate and body condition score 3–4 resulted in the lowest endometritis rate (P <
0.05). Corpus luteum was found in 9.67% of the cows suffering from endometritis, while the rest developed various types of subfertility
(P < 0.05). Three groups of cows (A, B, and C) with an almost equal number of clinical and subclinical endometritis diagnoses were
formed. All of the groups received prostaglandin analogues (PGF Veyx Forte®, Veyx Pharma) intramuscularly 3 times at 11 day intervals.
In group A, only prostaglandins were used; in group B, cephapirin (Metricure®, Intervet Schering-Plough) was administered into the
corpus uteri simultaneously with the first 2 doses of prostaglandins; and in group C, the first 2 doses of prostaglandins were followed by
the ozone product Riger Spray® (Novagen, Italy) applied into the uterus. The criteria applied for the therapy success were the number of
cows conceived after the first artificial insemination and the number of days open. The best therapy results were achieved in groups C
and B (P < 0.05), with the advantage of no milk and meat withdrawing period in the animals of group C.
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1. Introduction
Parkinson (1) reported that one of the most important causes
of subfertility in dairy cows is endometritis (E). LeBlanc et
al. (2) and Lewis (3) described E as inflammation of the
uterus involving the endometrium. Bonnett et al. (4) and
Bretzlaff (5) reported that E involves only the endometrium
without any systemic signs. According to Kasimanickam
et al. (6), E is inflammation of the endometrium associated
with delayed uterine involution and poor reproductive
performance classified into 2 categories: clinical (CE)
and subclinical (SE). LeBlanc et al. (2) defined CE as the
presence of purulent or mucopurulent uterine discharge
detectable externally or in the anterior vagina and/or with
a cervical diameter greater than 7.5 cm and a uterine-horn
diameter of >8 cm after 30 days postpartum. According to
Kasimanickam et al. (6) and LeBlanc et al. (2), SE can be
defined as the presence of fluid (using ultrasonography)
in the uterine lumen at 31 days postpartum or later, with
a cervical diameter of between 5 and 7 cm and a uterine
diameter of between 5 and 8 cm.
Bruun et al. (7) reported that problems such as dystocia
and retained placenta (or retained fetal membranes;
RFM) greatly increased the odds of metritis. According
* Correspondence: robert.zobel@sk.t-com.hr
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to Sheldon et al. (8) and Opsomer et al. (9), animals with
greater bacterial growth in the uterus tend to develop
different types of subfertility when compared to normal
postpartum cows.
LeBlanc et al. (10), Kasimanickam et al. (11), Heuwieser
et al. (12), and Bretzlaff (5) reported that various treatment
approaches have been used, including parenteral
administration or intrauterine infusion of antibiotics and
intramuscular administration of prostaglandin analogues.
A variety of antibiotics have been infused into the uterus
of cows in attempts to treat postpartum infections.
Kasimanickam et al. (11) reported that ceftiofur is
suggested as an alternative if the patient does not appear to
respond to penicillin administration. According to Adams
(13), cephapirin is resistant to the action of penicillinase
and is active in an anaerobic environment as present in an
infected uterus.
Ozone (O3) is unstable gas with a tendency of quickly
transforming into oxygen and its antibacterial activity can
be more effective than iodine and chlorine, as stated by
Silva et al. (14). Data reported by Bocci (15) showed that
bacteria, spores, and viruses are inactivated by O3 after
only few minutes of exposure. Ozone may act through

ZOBEL / Turk J Vet Anim Sci
mechanisms other than oxidation, including the activation
of erythrocyte metabolism and immune cells, as reported
by Zimran et al. (16), and as a disinfectant, especially for
anaerobic bacteria. With bactericidal, as reported by Silva
et al. (14), immune-stimulating, as reported by Zimran
et al. (16), and antiinflammatory properties, as reported
by Gretchkanev et al. (17), O3 therapy has the potential to
alleviate the clinical signs of E. Ogata and Nagahata (18)
also reported that local administration of O3 was successful
in treating mastitis in dairy cows.
In the presented study, an attempt was made to
establish the incidence of CE and SE and to evaluate the
influence of the body condition score (BCS), previous
dystocia, and RFM on their incidence. At the same time,
different therapy option successes were compared using
parental prostaglandin analogues (PGF Veyx Forte®,
Veyx Pharma) with intrauterine cephapirin (Metricure®,
Intervet Schering-Plough) or the O3 product Riger Spray®
(Novagen) in cows suffering from CE and SE, starting
from day 30 to day 35 postpartum.
2. Materials and methods
2.1. Animals
A total of 1300 cows were enrolled in the study, conducted
from 1 February 2007 to 1 June 2010 in central Croatia.
The animals were kept at 43 commercial dairy farms with
65 ± 26 cows per farm, an average of 5150 ± 590 kg of milk,
and similar management. The average age of the involved
cows was 5.3 ± 2.7 years.
Exclusion criteria included receiving systemic
antibiotic therapy within 7 days prior to involvement in
the study, intrauterine therapy or reproductive hormone
administration in the current lactation, abnormal internal
genitalia (including adhesions), previous cesarean section,
a BCS of <2, fever of any origin, and systemic diseases.
2.2. Examination protocol
The first postpartum examination was carried out between
days 30 and 35 postpartum by vaginoscopy, transrectal
palpation, and ultrasonography with a rectal linear probe (7
MHz, Draminski, PROFI L, Poland). During vaginoscopy,
the vaginal content and cervical morphology were
monitored. Following vaginoscopy, transrectal palpation
of the reproductive tract was performed to determine
the diameter, location, consistency, and symmetry of
uterine horns; the presence of fluid in the uterus; and the
presence of structures on the ovaries (follicle, luteinized
follicle, corpus luteum (CL), cyst, and scars). In addition,
ultrasonography was used for the measurement of the
cervical size and diameter of the uterine horns with
imaging of abnormal fluid in the uterine lumen. Normal
fluid was considered as a clear fluid at the anterior vagina
(using vaginoscopy), or in the uterine lumen with a
heterogenic appearance, using ultrasonography. Based on

the reproductive examination, the cows were grouped into
3 categories: CE, SE, and sound cows (noE). Cows with
a cervical size of >7 cm, uterine diameter of >8 cm, and
a purulent or mucopurulent discharge visible through the
speculum were classified as having CE. Cows with a cervical
size of <7 cm, uterine horns with diameter of 5–8 cm, and
abnormal fluid in the uterus visible at ultrasonography
were classified as having SE. Cows classified as sound had
a cervical size of <7 cm, uterine diameter of <5 cm, and no
abnormal discharge externally or in the uterus based on
ultrasonographic findings.
Anovulatory estrus was confirmed by ultrasonography
and transrectal palpation after finding the follicle of
unchanged morphology on a given ovary 7 days after the
onset of estrus, as described by Watson and Harwood (19).
Cystic ovarian disease (COD) was diagnosed when
one or more fluid-filled structures were found on the
ovaries, unilaterally or bilaterally, measuring more than 3
cm in diameter and persisting for 10 or more days with
the absence of CL, according to the criteria previously
established by Hanzen et al. (20). COD was diagnosed
by transrectal palpation and confirmed by transrectal
ultrasonography. In these cases, the difference between
luteal and follicular cysts was not considered an important
criterion for the diagnosis of COD.
According to previous reports that provided
descriptive guidelines for diagnosing anestrus given by
Peter (21), anestrus was confirmed for all of the cows/
heifers presented with smooth, round to oval, and small
ovaries (size of a pea) that failed to come into heat by 100
days postpartum.
The CL finding was established according to the
report by Parkinson (1) using transrectal palpation and
ultrasonography.
Each herd was visited once weekly for regular
reproductive examinations, which included the detection
and treatment of reproductive disorders, pregnancy
diagnosis, artificial insemination (AI), and recording of
the BCS at a scale of 1 to 5 with 0.5 increment points,
according to Edmonson et al. (22). Cows that were 30
to 35 days postpartum were included in the study and
examined until the confirmation of E was diagnosed, or AI
or confirmed pregnancy. All data were recorded entering
the study regarding the date of calving, calving condition
(normal or dystocia: any difficulty in calving that required
assistance, RFM), and age.
2.3. Group formation
Cows with confirmed E were classified into those with CE
or SE based on the findings. After that, the animals were
randomly divided into 3 groups (A, B, and C) based on
the last 2 ear-tag numbers. The cows were examined and
the groups were formed until there was almost an equal
proportion of cows with 2 different stages of E in each
group.
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2.4. Treatment protocol
All of the groups received an intramuscular (IM) injection
of 0.05 mg of cloprostenol (2 mL of PGF Veyx Forte) 3 times
at 11 day intervals. The first injection was administered
on the same day that the E diagnosis was established. The
cows were artificially inseminated 3 days following the
third injection of cloprostenol. Insemination was followed
by the IM injection of 0.05 mg of gonadorelin (1 mL of
Depherilin Gonavet Veyx®, Veyx Pharma). The cows
were inseminated daily until transrectal confirmation of
ovulation (disappearance of dominant follicle).
The cows in group A (n = 101) received only
cloprostenol.
In group B (n = 96), 500 mg of cephapirin (Metricure)
was administered into the uterus at the same time as the
first and the second dose of cloprostenol.
The cows in group C (n = 103) received 20 mL of O3
product (Riger Spray) into the uterus at the same time as
the first and the second dose of cloprostenol.
Pregnancy was diagnosed 40 days following AI using
ultrasonography. The number of pregnant cows following
the first AI and number of days open in all of the groups
were recorded for further data analysis.
2.5. Statistical analyses
Data were analyzed with the Statistica 8 statistical software
program. Models were created with a multivariate logistic
regression. The outcome measures were the number of
animals conceived following the first AI and the number
of days open. Variables included in the model were the
E status (CE, SE, and noE), presence of CL, anovulatory
estrus, anestrus, COD, BCS, previous dystocia, and RFM.
Relevant interaction terms were also tested. Results were
significant when P < 0.05.
3. Results
3.1. Endometritis incidence
Out of the 1300 observed cows, E was diagnosed in 300
(23.07%), with CE in 199 (15.31%) and SE in 101 (7.77%).
As presented in the Figure, CE was almost 2-fold more
frequent than SE.
3.2. Dystocia and endometritis incidence
Out of a total of 1300 cows, 101 (7.77%) suffered from
dystocia at birth. Dystocia resulted in CE in 41 (40.59%)
and SE in 48 (47.52%) cows (P > 0.05), while in 12
(11.88%) cows, E was not observed (P < 0.05). The results
are presented in Table 1.
3.3. Placental retention and endometritis incidence
As presented in Table 1, out of the 1300 observed cows,
88 cows (6.77%) suffered from RFM during the previous
birth. Consequently, only 19.3% of the cows suffering from
RFM did not develop E (P < 0.05).
3.4. Body condition score and endometritis incidence
The highest CE and SE rate was noticed in cows having a
BCS of 2, 2.5, 4.5, and 5 (P < 0.05), while the lowest CE and
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Figure. Clinical and subclinical endometritis (E) ratio over a
3-year period (n = 1300). Total sample n = 1300; CE, clinical E (n
= 199); and SE, subclinical E (n = 101).

SE rate was recorded in cows having a BCS of 3 to 4 (P <
0.05). The results are presented in Table 1.
3.5. Endometritis and ovarian function
As shown in Table 2, the highest impact of CE and
SE diagnosis on the ovarian function manifested with
anestrus (P < 0.05). In cows with an E diagnosis, CL was
found in only 9.67% of the animals (P < 0.05). When
compared to the noE group, CL was found in almost half
of the examined animals (P < 0.05).
3.6. Therapy success
As presented in Table 3, the most efficient therapy was
achieved in groups B and C (P < 0.05), where 1.7 times
more cows conceived following the first posttreatment
AI and 1.5 times fewer days open were recorded when
compared to group A.
4. Discussion
The objectives of this study were to evaluate the incidence
of CE and SE, together with the influence of dystocia,
BCS, and RFM on the E rate. Different treatment options
were compared, including the parenteral application
of hormones and intrauterine application of antibiotic
(cephapirin) versus O3 product on the outcome of E,
measured by the first successful posttreatment AI and the
number of days open.
The incidence of CE in the study conducted by LeBlanc
et al. (2) was 16.9% and is similar to presented results
(15.3%).
Increased incidence of postpartum E following
abnormal calving (dystocia) is consistent with the results
of Gautam et al. (23) and Markusfeld (24), but in contrast
to those of Kim and Kang (25). Here, dystocia increased
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Table 1. Influence of dystocia, retention of fetal membranes, and body condition score on the clinical and subclinical E incidence.

D
%

SE
(Av ± SD)

%

7.77
(101/1300)

CE
(Av ± SD)

noE
(Av ± SD)

0.4 ± 0.49a

40.59 (41/101)

0.47 ± 0.5a

47.52 (48/101)

0.12 ± 0.32b

11.88
(12/101)

(Av ± SD)

%

%

0.07 ± 0.25

0.43 ± 0.5a

0.38 ± 0.49a

37.50
(33/88)

no E
(Av ± SD)

%

43.18
(38/88)

SE
(Av ± SD)

%

6.77
(88/1300)

CE
(Av ± SD)

0.19 ± 0.4b

19.32
(17/88)

%

CE
(Av ± SD)

%

SE
(Av ± SD)

%

no E
(Av ± SD)

%

(Av ± SD)

%

0.08 ± 0.27

%

RFM

BCS

2
2.5
3
3.5
4
4.5
5

6.77
(88/1300)
9.071
(118/1300)
21.232
276/1300
22.382
291/1300
22.772
296/1300
9.152
119/1300
8.612
112/1300
1

0.58 ± 0.51
0.32 ± 0.472
0.04 ± 0.193
0.03 ± 0.173
0.06 ± 0.243
0.25 ± 0.444
0.37 ± 0.492

57.95
(51/88)
32.2
(38/118)
3.98
(11/276)
3.09
(9/291)
6.08
(18/296)
25.21
(30/119)
37.50
(42/112)

0.26 ± 0.441
0.19 ± 0.392
0.02 ± 0.133
0.01 ± 0.123
0.02 ± 0.143
0.16 ± 0.372
0.2 ± 0.42

26.13
(23/88)
18.64
(22/118)
1.81
(5/276)
1.37
(4/291)
2.02
(6/296)
15.97
(19/119)
19.64
(22/112)

0.16 ± 0.371
0.49 ± 0.52
0.94 ± 0.233
0.96 ± 0.213
0.92 ± 0.273
0.59 ± 0.492
0.43 ± 0.52

15.91
(14/88)
49.15
(58/118)
94.2
(260/276)
95.53
(278/291)
91.89
(272/296)
58.82
(70/119)
42.86
(48/112)

D, dystocia; RFM, retention of fetal membranes; BCS, body condition score; CE, average number of clinical E cases expressed with
standard deviation (±SD); SE, average number of subclinical E cases expressed with ±SD; noE, average number of cows without E
diagnosis (sound cows) expressed with ±SD; Av, average; SD, standard deviation; and %, percent of animals expressed as total number
of animals in the respective subgroup in brackets.
a, b
Values in each row marked with a different letter in superscript differ significantly (P < 0.05).
1,2,3
Values in each column marked with a different number in superscript differ significantly (P < 0.05).

the odds of E. It can be presumed that dystocia can increase
the risk of trauma to the uterine wall, thus increasing the
odds of E. Moreover, calving assistance increases the risk
of introducing infection. The presented results are also
supported by the findings of Gröhn et al. (26).
E developed in 80% of the cows suffering from RFM.
These study results are supported by the reports of
Gautam et al. (23) that increased risk of E is connected
with RFM because RFM may serve as a perfect medium
for bacterial growth and increase the susceptibility for E.
The presented findings are also supported by Bruun et al.
(7), who reported that cows with RFM had higher odds of
E irrespective of the breed.

The highest CE and SE rates were observed in the
skinny as well as in the fat cows (having a BCS of 2 and 5).
At the same time, the lowest CE and SE rates were recorded
in cows having a BCS of 3 to 4. It can be speculated that
the BCS had a significant influence on the E development,
probably caused by different metabolic disorders, both in
the skinny as well as in the fat cows.
E showed significant impact on the ovarian function.
In the present study, less than 10% of the cows had normal
cycles resulting in a CL finding, while the rest developed
various types of subfertility. The presented results are
supported by those of Sheldon et al. (8) and Opsomer et
al. (9).
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Table 2. Influence of clinical and subclinical E on the ovarian function and observed subfertility diagnosis.

Subfertility
CE
(n = 199)

SE
(n = 101)

E (CE + SE)
(n = 300)

noE
(n = 1000)

COD

0.23 ± 0.42a

0.26 ± 0.44a

0.16 ± 0.371

0.05 ± 0.21b1

%

22.61
(45/199)

25.74
(26/101)

16.33
(49/300)

5.00
(50/1000)

AE

0.28 ± 0.45a

0.22 ± 0.42b

0.26 ± 0.442

0.21 ± 0.41b1

%

27.63
(55/199)

21.78
(22/101)

25.66
(77/300)

21.00
(210/1000)

A

0.41 ± 0.49a

0.33 ± 0.47b

0.25 ± 0.432

0.27 ± 0.44c2

%

40.70
(81/199)

32.67
(33/101)

24.67
(74/300)

27.00
(270/1000)

CL

0.09 ± 0.29a

0.2 ± 0.4b

0.09 ± 0.33

0.47 ± 0.5c3

%

9.04
(18/199)

19.80
(20/101)

9.67
(29/300)

47.00
(470/1000)

CE, clinical E; SE, subclinical E; COD, cystic ovarian disease; AE, anovulatory estrus; A, anestrus; CL, corpus luteum; and E (CE + SE),
sum of subfertility diagnoses expressed by the average and SD with percent in brackets.
a, b, c
Values in each row marked with a different letter in superscript differ significantly (P < 0.05).
1,2,3
Values in each column marked with a different number in superscript differ significantly (P < 0.05).
Table 3. Therapy success measured by the number of cows pregnant following the first
posttreatment AI and the number of days open.
Group A
(n =101)

Group B
(n = 96)

Group C
(n =103)

CP

51a

85b

91b

%

50.49

88.54

88.35

Av ± SD

0.4 ± 0.5

0.88 ± 0.32

0.88 ± 0.32

DO

108a

85b

80b

Av ±

108.25 ± 57.1

85 ± 32.78

79.91 ± 29.26

Therapy success

DO, days open; CP, cows pregnant following the first posttreatment AI; %, percent of pregnant
animals in the respective group; Av ± SD, average with SD; Av ±, average expressed with ± (min.
and max. values) in the respective group.
a, b
Values in each row marked with a different letter in superscript differ significantly (P < 0.05).

The best therapy results were achieved in group C, where
the animals were treated with prostaglandin analogues
parenterally and O3 product (as a novel treatment option)
applied into the uterus (group C). This treatment option
resulted in the highest number of cows conceived following
the first posttreatment AI and the lowest number of days
open. Slightly less effective, although not significantly,
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was the treatment combining prostaglandin analogues
and cephapirin (group B). The lowest therapy success was
achieved in group A. The results of the present study are
supported by those of Hendricks et al. (27), who reported
that treatment with prostaglandin analogues has no effect
on the incidence of CE. The poor therapy result in group
A could be the consequence of the ovarian status with the
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small number of cows having CL on their ovaries, and thus
ineffective prostaglandin treatment. Obviously, some kind
of treatment of the endometrium should be used in the
treatment of E, coupled with hormone administration. As
cows treated with O3 showed an increase in the number
of cows conceived following the first AI and decreased
number of days open, this is likely due to its disinfecting
effect coupled with an immunomodulative capacity of

the O3 at the level of contact with the uterine mucosa, as
reported by Jakab et al. (28). Therefore, O3 is likely to provide
a more favorable uterine environment for insemination
and fertilization by reducing the spermicidal effect and
E-related inflammation. Ozone products, combined with
prostaglandins, are slightly more effective than cephapirin
in postpartum E treatment with the advantage of no milk
(and meat) withdrawing period.
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